Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 3, 2024, Exact Sciences Corporation (the "Company" or "Exact Sciences") announced leadership updates as it prepares for an exciting period of growth and the launches of new breakthrough cancer tests to improve the lives of people around the world. The Company is moving its commercial organization, which includes exceptional sales and marketing leaders, directly under its Screening and Precision Oncology teams. The Company expects this will enhance its agility, transparency and responsiveness to patient and customer needs. Jake Orville and Brian Baranick will continue in their roles as General Managers of Screening and Precision Oncology, respectively, positions they have both held since 2022.
Exact Sciences also reported that on May 30, 2024, Everett Cunningham, Chief Commercial Officer, informed the Company that effective on June 13, 2024 he will be departing for an opportunity with an organization that does not compete with the Company.

Attachments

  • Original Link
  • Permalink

Disclaimer

EXACT Sciences Corporation published this content on 03 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 June 2024 11:04:06 UTC.